Diamyd Medical AB (publ)
DYMDF
$0.73
$0.000.00%
OTC PK
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -31.03% | -36.70% | -66.86% | -76.02% | -68.76% |
| Total Other Revenue | -- | -- | -- | -- | 200.00% |
| Total Revenue | -31.03% | -36.70% | -66.86% | -76.02% | -68.76% |
| Cost of Revenue | 3.26% | 4.21% | -9.79% | 1.60% | 14.48% |
| Gross Profit | -4.94% | -7.57% | 4.06% | -15.23% | -32.07% |
| SG&A Expenses | 23.56% | 14.50% | 15.34% | 12.73% | 9.30% |
| Depreciation & Amortization | 117.99% | 120.96% | 128.94% | 126.99% | -5.96% |
| Other Operating Expenses | -220.59% | -22.77% | -26.76% | -70.35% | 139.39% |
| Total Operating Expenses | 39.42% | 51.46% | 45.32% | 31.81% | 14.12% |
| Operating Income | -39.51% | -51.67% | -45.69% | -32.32% | -14.53% |
| Income Before Tax | -27.66% | -41.60% | -35.64% | -31.31% | -15.80% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -27.66% | -41.60% | -35.64% | -31.31% | -15.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.66% | -41.60% | -35.64% | -31.31% | -15.80% |
| EBIT | -39.51% | -51.67% | -45.69% | -32.32% | -14.53% |
| EBITDA | -40.36% | -53.22% | -46.92% | -33.09% | -15.02% |
| EPS Basic | -11.61% | -20.32% | -11.96% | -8.35% | 1.02% |
| Normalized Basic EPS | -10.12% | -18.86% | -10.41% | -1.96% | 1.09% |
| EPS Diluted | -11.61% | -20.32% | -11.96% | -8.35% | 1.02% |
| Normalized Diluted EPS | -10.12% | -18.86% | -10.41% | -1.96% | 1.09% |
| Average Basic Shares Outstanding | 14.02% | 17.87% | 21.60% | 20.98% | 17.44% |
| Average Diluted Shares Outstanding | 14.02% | 17.87% | 21.60% | 20.98% | 17.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |